Polyoxidonium is a combined innovative product with immunomodulating, detoxifying, and antioxidative action. International name: azoximer bromide.

Polyoxidonium is produced by the Russian pharmaceutical company NPO Petrovaks Farm. It was first synthesized in 2002.

Used in treatment of acute and chronic infectious diseases of bacterial, viral, or fungal origin.

For fast and flue:

  • helps to cope with the infection almost 2 times faster;
  • improves well-being from the first days of treatment;
  • Reduces the incidence of influenza and ARVI in the prevention.

The high efficacy of Polyoxidonium is confirmed by numerous clinical studies and 20 years of usage experience in various therapeutic areas.


For oral or sublingual (for 20-30 minutes in cases of respiratory diseases) before meals daily 2 times a day: children over 10 years old and adults 1 tablet, children from 3 to 10 years old ½ tablet (6 mg). Course is 7 up to 10 days.

If there is no improvement after treatment, or symptoms intensify, or new symptoms appear, you should consult with your doctor.

No potential side effects reported.

If allergic reactions occur, discontinue use of Polyoxidonium® and consult a doctor.